SCHALL THOMAS J. (President and CEO) sold 5.2% of their position (130K shares) of CHEMOCENTRYX, INC. on the open market
Open‑market sale worth $6.53M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/8/2022ACC: 0001209191-22-044896
DirectorOfficer· President and CEO
Since Jun 2018
-130K
Net shares
Net seller
$6.53M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
130K acquired · 260K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+130K
Price / share
$14.28
Trade value
$1.86M
% of position
5.4%
8/4/2022
2.39M→2.52M
Common Stock
Direct
Shares
−130K
Price / share
$50.24
Trade value
$6.53M
% of position
5.2%
8/4/2022
2.52M→2.39M
Total
Net shares
+0.00
Net value
-$4.68M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/4/2022 | M · Option Exercise | +130K | $14.28 | $1.86M | 5.4% | 2.39M | 2.52M |
| Common Stock Direct | 8/4/2022 | S · Sale | −130K | $50.24 | $6.53M | 5.2% | 2.52M | 2.39M |
| Total | +0.00 | -$4.68M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
130K shares
Shares
−130K
Strike price
14.28
Held after
35K
Exercisable
—
8/4/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock130K shares | 8/4/2022 | M · Option Exercise | −130K | 14.28 | — | 35K |